Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $1.1 million.

  • Exagen's Other Non-Current Assets rose 8738.9% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 8738.9%. This contributed to the annual value of $550000.0 for FY2024, which is 1071.43% down from last year.
  • According to the latest figures from Q3 2025, Exagen's Other Non-Current Assets is $1.1 million, which was up 8738.9% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Other Non-Current Assets registered a high of $1.3 million during Q2 2025, and its lowest value of $235000.0 during Q2 2021.
  • Over the past 5 years, Exagen's median Other Non-Current Assets value was $586000.0 (recorded in 2022), while the average stood at $599684.2.
  • In the last 5 years, Exagen's Other Non-Current Assets skyrocketed by 16595.74% in 2022 and then plummeted by 1725.81% in 2024.
  • Quarter analysis of 5 years shows Exagen's Other Non-Current Assets stood at $433000.0 in 2021, then grew by 21.94% to $528000.0 in 2022, then increased by 16.67% to $616000.0 in 2023, then fell by 10.71% to $550000.0 in 2024, then skyrocketed by 91.82% to $1.1 million in 2025.
  • Its Other Non-Current Assets was $1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and $596000.0 in Q1 2025.